AN2 Therapeutics OverviewAN2 Therapeutics Net Income
Profitability analysis for ANTX.
Quarterly Net Income
-$10.03M
↑ 5.83% YoY
As of Mar 2026
Annual Net Income (TTM)
-$34.55M
↑ 23.81% YoY
Trailing 12 months ending Mar 2026
Average Net Income (Comparison Companies)
Net Income History
Net Income Comparison
Annual Net Income Growth Rate (%)
Loading...
Annual Net Income Growth (Absolute)
Loading...